Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
NCT ID: NCT06970990
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
26 participants
INTERVENTIONAL
2025-05-20
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Lung Aeration and Inspiratory Effort With and Without Awake Prone
NCT05719103
Quantification of Inspiratory Effort Through Nasal Pressure in Patients Undergoing Weaning From Invasive Mechanical Ventilation and Correlation With Clinical Outcomes
NCT05282238
The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy
NCT05298319
Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure
NCT06582459
INSPIRatory Efforts Estimation Under High-flow Nasal Oxygen
NCT07228676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Esophageal pressure fluctuations (ΔPes), as a reflection of mean transpulmonary pressure during unassisted voluntary breathing, provide an important basis for assessing inspiratory effort.However, esophageal manometry still faces many challenges for its bedside implementation in clinical practice, especially in unstable patients with respiratory distress and severely impaired gas exchange.Notably, the COVID-19 pandemic has led to a significant increase in the number of patients with acute respiratory failure, who often require condition-specific oxygen therapy of varying severity and are mostly treated outside the ICU.Given that such patients are at high risk of deterioration, it is particularly important to continuously monitor their inspiratory effort.
nasal pressure is an important physiological indicator for assessing upper airway resistance and airflow dynamics characteristics, whereas esophageal pressure is a key parameter that directly reflects intrathoracic pressure and respiratory effort.Previous studies have shown that there may be a physiological correlation between intranasal pressure and oesophageal pressure, and that this correlation may be influenced by a variety of factors, including airflow velocity, oxygen concentration, and the dynamics of upper airway resistance.Earlier physiological studies by comparing oesophageal pressure fluctuations (ΔPes) with nasal pressure fluctuations (ΔPnose) fluctuations found that when inspiratory effort was increased, there was no significant phase difference between these pressure waveforms.In addition, it was observed that there was a significant correlation between ΔPes and airway pressure fluctuations (ΔPaw) obtained by airway occlusion manoeuvres during inspiratory effort testing.However, although these findings provide important clues for understanding respiratory mechanics, studies on the correlation between nasal pressure and esophageal pressure under different oxygen therapy conditions are still relatively limited, especially lacking data support from prospective physiological studies.Therefore, further systematic studies are needed in the future to investigate in depth the effects of different oxygen therapy parameters (e.g., flow rate, humidity, and temperature, etc.) on the relationship between nasal pressure and esophageal pressure, so as to provide more precise guidance for clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HFNC:flow=50L/min
Under high-flow oxygen therapy at a flow rate of 50 L/min, record/monitor for 5 minutes
HFNC:50L/min
Under high-flow oxygen therapy at a flow rate of 50 L/min, record/monitor for 5 minutes
HFNC:flow=40L/min
Under high-flow oxygen therapy at a flow rate of 40 L/min, record/monitor for 5 minutes
HFNC:flow=40L/min
Under high-flow oxygen therapy at a flow rate of 40 L/min, record/monitor for 5 minutes.
HFNC:flow=30L/min
Under high-flow oxygen therapy at a flow rate of 30 L/min, record/monitor for 5 minutes
HFNC:flow=30L/min
Under high-flow oxygen therapy at a flow rate of 30 L/min, record/monitor for 5 minutes.
Face Mask Oxygen:8L/min
Under face mask oxygen at a flow rate of 8 L/min, record/monitor for 5 minutes.
Face mask oxygen:8L/min
Under face mask oxygen at a flow rate of 8 L/min, record/monitor for 5 minutes.
Face Mask Oxygen:5L/min
Under face mask oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.
Face mask oxygen:5L/min
Under face mask oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.
Nasal cannula oxygen:5L/min
Under nasal cannula oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.
Nasal cannula oxygen:5L/min
Under nasal cannula oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.
Nasal cannula oxygen:3L/min
Under nasal cannula oxygen at a flow rate of 3 L/min, record/monitor for 5 minutes.
Nasal cannula oxygen:3L/min
Under nasal cannula oxygen at a flow rate of 3 L/min, record/monitor for 5 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HFNC:flow=40L/min
Under high-flow oxygen therapy at a flow rate of 40 L/min, record/monitor for 5 minutes.
HFNC:flow=30L/min
Under high-flow oxygen therapy at a flow rate of 30 L/min, record/monitor for 5 minutes.
Face mask oxygen:8L/min
Under face mask oxygen at a flow rate of 8 L/min, record/monitor for 5 minutes.
Face mask oxygen:5L/min
Under face mask oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.
Nasal cannula oxygen:5L/min
Under nasal cannula oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.
Nasal cannula oxygen:3L/min
Under nasal cannula oxygen at a flow rate of 3 L/min, record/monitor for 5 minutes.
HFNC:50L/min
Under high-flow oxygen therapy at a flow rate of 50 L/min, record/monitor for 5 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Respiratory stability:Capable of spontaneous breathing with effective cough for secretion clearance.Oxygen saturation (SpO₂) \> 90% or PaO₂/FiO₂ ≥ 150 mmHg when receiving nasal cannula oxygen at 3 L/min;
3. Hemodynamic stability:Heart rate (HR) ≤ 120 bpm;Systolic blood pressure (SBP) 90-150 mmHg;No vasoactive medications OR norepinephrine dosage \< 0.1-0.2 μg/kg·min (or equivalent doses of other vasoactive agents);
4. Metabolic stability;
5. Compliance with medical instructions.Able to follow prescribed tasks.Esophageal pressure monitoring catheter already in place;
6. Patient or legal guardian agrees to participate and has signed the informed consent form.
Exclusion Criteria
2. Pregnancy;
3. Hemodynamic instability:Mean arterial pressure (MAP) \< 60 mmHg.Heart rate (HR) \> 120 bpm or \< 60 bpm;
4. Respiratory instability:Respiratory rate (RR) \> 35 bpm.Oxygen saturation (SpO₂) \< 90%;
5. Neuromuscular diseases or phrenic nerve injury;
6. Recent trauma or surgery involving the trachea, esophagus, neck, or chest.Contraindications to esophageal catheter placement or inability to monitor esophageal pressure;
7. Nasal obstruction or anatomical abnormalities:Complete nasal obstruction.Severe anatomical abnormalities (e.g., severe septal deviation, nasal polyps, or tumors) preventing catheter placement or compromising ventilation;
8. High-risk craniofacial conditions:Severe facial trauma or skull base fracture with risk of catheter misplacement into the intracranial space.Active epistaxis or incomplete healing after nasal surgery;
9. Bleeding risk:Severe coagulopathy.Esophageal/gastric varices or other conditions predisposing to hemorrhage.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jian-Xin Zhou
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jian-Xin Zhou
Head of Emergency and Critical Care Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jian-Xin Zhou, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Shijitan Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIT2025-031-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.